Monday, January 21, 2019

Dry Eye

Botox, not just for wrinkles.

A new study suggests it may also help dry eye. The research team did a retrospective chart review of 76 patients who received Botox to treat their...

What your patient might ask you…

Does vitamin D help my dry eye? A new study published in Eye & Contact Lens found a link between vitamin D deficiency and dry eye. The study...

What your patient might ask you…

Can you really kill someone with Visine? I've never tried but a woman admitted to killing her husband by poisoning him with Visine. How exactly? Visine contains tetrahydrozoline which is...

New FDA approval: OXERVATE.

Oxervate was approved on August 22nd for the treatment of neurotrophic keratitis. Refresh me on neurotrophic keratitis. Patients with neurotrophic keratitis have decreased corneal sensitivity, epithelial breakdown,...

And then there were three.

We've got a new dry eye med to prescribe. The FDA just approved Cequa ("see-qwa"), a prescription eye drop indicated to increase tear production in patients...

What your patient might ask you…

Are there any new drops for dry eye? Always. Allergan announces the launch of Refresh Repair lubricant eye drops. How is this different than all the others? This over-the-counter drop is focused...

If you see dry eye patients…

A new study showed 7 out of 10 dry eye patients have meibomian gland dysfunction.

What was the most talked about study last week?

The DREAM study. What's the DREAM study? The Dry Eye Assessment and Management trial. It's a year long study to evaluate the effects of long-term omega-3 supplementation...

The artificial tear aisle continues to overwhelm patients.

Alcon introduces Systane Complete. This artificial tear gives relief to patients with evaporative dry eye, aqueous deficient dry eye, and/or a combo of both.

Weekly social media roundup.

What is the most attractive eye color? Science says blue eyes. (via) 11.4 Million. The number of cases of dry eye syndrome in women in 2016. Men had...

Want this news in your inbox?

Subscribe to the weekly email (it’s free!)